Measuring the level of severity in pharmacoeconomic analyses

Measuring the level of severity in pharmacoeconomic analyses


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 2,675

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Economic evaluations are increasingly being used to inform decision makers regarding the allocation of scarce health care resources. In reimbursement applications to the Norwegian Drug Reimbursement Scheme the cost-utility analysis (CUA) is a common feature, expressing the cost-effectiveness of a treatment. Norwegian Medicines Agency (NoMA), which administers the scheme, is interested in supplementing the existing dossier with measurements of the conditions severity level. During their work on revising the pharmacoeconomic guidelines they identified a lack of empirical studies concerning severity measures. The objective is to find out how to operationalize severity measurements in a Norwegian context and investigate the implications of the included severity measures; providing a contribution to the discussion of severity level in Norway.

Product Specifications
SKU :COC74767
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08
0 Review(s)